Shelton Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,600
| Closed | -$1.29M | – | 759 |
|
|
2024
Q1 | $1.29M | Hold |
13,600
| – | – | 0.04% | 262 |
|
|
2023
Q4 | $1.21M | Hold |
13,600
| – | – | 0.04% | 258 |
|
|
2023
Q3 | $993K | Hold |
13,600
| – | – | 0.04% | 266 |
|
|
2023
Q2 | $1.13M | Sell |
13,600
-80
| -0.6% | -$6.66K | 0.04% | 257 |
|
|
2023
Q1 | $1.04M | Hold |
13,680
| – | – | 0.04% | 233 |
|
|
2022
Q4 | $1.14M | Buy |
13,680
+80
| +0.6% | +$6.64K | 0.12% | 195 |
|
|
2022
Q3 | $1.08M | Hold |
13,600
| – | – | 0.05% | 236 |
|
|
2022
Q2 | $1.01M | Hold |
13,600
| – | – | 0.05% | 252 |
|
|
2022
Q1 | $1.22M | Hold |
13,600
| – | – | 0.05% | 251 |
|
|
2021
Q4 | $1.52M | Hold |
13,600
| – | – | 0.05% | 247 |
|
|
2021
Q3 | $1.71M | Hold |
13,600
| – | – | 0.07% | 237 |
|
|
2021
Q2 | $1.84M | Hold |
13,600
| – | – | 0.07% | 232 |
|
|
2021
Q1 | $1.85M | Hold |
13,600
| – | – | 0.06% | 246 |
|
|
2020
Q4 | $1.92M | Buy |
13,600
+2,800
| +26% | +$394K | 0.09% | 205 |
|
|
2020
Q3 | $1.2M | Sell |
10,800
-1,200
| -10% | -$134K | 0.05% | 319 |
|
|
2020
Q2 | $1.34M | Hold |
12,000
| – | – | 0.07% | 213 |
|
|
2020
Q1 | $929K | Hold |
12,000
| – | – | 0.07% | 220 |
|
|
2019
Q4 | $1.14M | Buy |
+12,000
| New | +$1.14M | 0.06% | 223 |
|